Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors

Radiographics

Volumn 21, Issue SPEC.ISS., 2001, Pages

  Rhim, Hyunchul ^a   Goldberg, S Nahum ^b   Dodd III, Gerald D ^c   Solbiati, Luigi ^d   Lim, Hyo Keun ^e   Tonolini, Massimo ^d   Cho, On Koo ^a  

^a Hanyang University College of Medicine   (South Korea)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d Ospedale Generale   (Italy)

^e Samsung Medical Center   (South Korea)

Author keywords

Interventional prodecures, technology; Liver neoplasms, therapy, 761.1269; Liver, interventional procedure, 761.1269; Radiofrequency (RF) abladen

Indexed keywords

CANCER STAGING; CATHETER ABLATION; ENDOSCOPIC ECHOGRAPHY; HUMAN; INTERVENTIONAL RADIOLOGY; LIVER TUMOR; METHODOLOGY; MINIMALLY INVASIVE SURGERY; REVIEW;

CATHETER ABLATION; HUMANS; LIVER NEOPLASMS; NEOPLASM STAGING; RADIOGRAPHY, INTERVENTIONAL; SURGICAL PROCEDURES, MINIMALLY INVASIVE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0035489422     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiographics.21.suppl_1.g01oc11s17     Document Type: Article

References (54)

1. Farmer DG, Rosve MH, Shaked A, et al. Current treatment modalities for hepatocellular carcinomas. Ann Surg 1994; 219:236-247.
2. Fong Y, Blumgart LH, Cohen AM. Surgical treatment of colorectal metastases to the liver. Cancer J Clin 1995; 45:50-62.
3. Fong Y, Kemedy N, Paty P, Blumgart LH, Cohen A. Treatment of colorectal cancer: hepatic metastases. Semin Surg Oncol 1996; 12:219-252.
4. Franco D, Capussotti L. Smadja, et al. Resection of hepatocellular carcinoma: results in 72 European patients with cirrhosis. Gastroenterology 1990; 98:733-738.
5. Dodd GD 3rd, Soulen M, Kane R, et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of major breakthrough. RadioGraphics 2000; 20:9-27.
6. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2001; 217:633-646.
7. McGahan JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001; 176:3-16.
8. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167:759-768.
9. Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: percutaneous radio-frequency ablation with cool-tip electrodes. Radiology 1997; 205: 367-373.
10. Rhim H, Dodd GD 3rd. Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound 1999; 27:221-229.
11. Siperstien AE, Gitomirski A. History and technological aspects of radiofrequency thermoablation. Cancer J 2000; 6(suppl 4):5293-5303.
12. Goldberg SN, Solbiati L, Halpern EF, Gazelle GS. Variables affecting proper system grounding for radiofrequency ablation in an animal model. J Vasc Interv Radiol 2000; 11:1069-1075.
13. Goldberg SN, Gazelle SG, Muller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174:323-331.
14. Organ LW. Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol 1976-77; 39:69-76.
15. LeVeen RF. Laser hyperthermia and radiofrequency ablation of hepatic lesions. Semin Interv Radiol 1997; 4:313-324.
16. Rossi S, Buscarini E, Garbangnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998; 170:1015-1022.
17. Goldberg SN, Stein MC, Gazelle GS, Sheiman RG, Kruskal JB, Clouse ME. Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol 1999; 10:907-916.
18. Goldberg SN, Solbiati L, Hahn PF, et al. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 1998, 209:371-379.
19. McGahan JP, Gu WZ, Brock JM, Tesluk H, Jones CD. Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol 1996; 3:418-422.
20. Miao Y, Yicheng N, Stefaan M, et al. Ex vivo experiment on radiofrequency liver ablation with saline infusion through a screw-tip cannulated electrode. J Surg Res 1997; 71:19-24.
21. Goldberg SN, Ahmed M, Gazelle GS, et al. Radio-frequency thermal ablation with adjuvant saline injection: effect of electrical conductivity on tissue heating and coagulation. Radiology 2001; 219:157-165.
22. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9:101-115.
23. Goldberg SN, Hahn PF, Halpern E, Fogle R, Gazelle GS. Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology 1998; 209:761-767.
24. Hansen PD, Rogers S, Corless CL, Siperstien AE. Swanstrom LL. Radiofrequency ablation lesions in a pig liver model. J Surg Res 1999; 87:114-121.
25. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217:119-126.
26. Goldberg SN, Saldinger PF, Gazelle GS, et al. Percutaneous tumor ablation: increased coagulation necrosis with combined radiofrequency and percutaneous doxorubicin injection (abstr). AJR Am J Roentgenol 2000; 174:34.
27. McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001; 176:3-16.
28. Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998; 227:566-571.
29. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998; 227:559-565.
30. Frank MS, Dodd GD 3rd, Chintapalli KN, Chopra S. Frequent local tumor recurrence after radiofrequency thermal ablation of hepatic tumors: a computer-generated 3-D model for ensuring adequate ablation (abstr). Radiology 1999; 213(P): 509.
31. Francica G, Marone G. Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a "cooled-tip needle": a preliminary clinical experience. Eur J Ultrasound 1999; 9:145-153.
32. Lencioni R, Goletti O, Armillotta N, et al. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998; 8:1205-1211.
33. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214:761-768.
34. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Radiofrequency ablation vs ethanol injection in the treatment of small hepatocellular carcinoma. Radiology 1999; 210:655-661.
35. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167:759-768.
36. Solbiati L, Ierace T, Goldberg SN, et al. Percutaneous US-guided RF tissue ablation of liver metastases: results of treatment and follow-up in 16 patients. Radiology 1997; 202:195-203.
37. Bartolozzi C, Lencioni R, Ricci P, Paolicchi A, Rossi P, Passariello R. Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. Radiology 1998; 209:387-393.
38. Gurney JM, Lee FT Jr, Cha C, Markhardt BK, Mahvi DM, Warner TF. CT vs ultrasound (US) for guidance of radiofrequency (RF) ablation in a porcine liver model: radiologic-pathologic correlation (abstr). Radiology 1999; 213(P):123.
39. Dromain C, De Baere TJ, Elias D, Ducre M, Sabourin J, Vanel D. Follow-up imaging of liver tumors treated using percutaneous radio frequency (RF) therapy with helical CT and MR imaging (abstr). Radiology 1999; 213(P):382.
40. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 2000; 88:2452-2463.
41. Merkle EM, Boll DT, Boaz T, et al. MRI-guided radiofrequency thermal ablation of implanted VX2 liver tumors in a rabbit model: demonstration of feasibility at 0.2 T. Magn Reson Med 1999; 42: 141-149.
42. Koito K, Namieno T, Ichimura T, et al. Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy. AJR Am J Roentgenol 2000; 174:337-341.
43. Lencioni R, Caramella D, Bartolozzi C. Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection. Radiology 1995; 194:113-118.
44. Sumi S, Yamashita Y, Mitsuzaki K, et al. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma. AJR Am J Roentgenol 1999; 172:67-71.
45. Hosoki T, Mitomo M, Choi S, Miyahara N, Ohtani M, Morimoto K. Visualization of tumor vessels in hepatocellular carcinoma. Acta Radiol 1997; 38:422-427.
46. Burns PN. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996; 51(suppl 1): 50-55.
47. Kono Y, Moriyasu F, Mine Y, et al. Gray-scale second harmonic imaging of the liver with galactose-based microbubbles. Invest Radiol 1997; 32: 120-125.
48. Harvey CJ, Blomley MJK, Eckersley RJ, Heckemann RA, Butler-Barnes J, Cosgrove DO. Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. Lancet 2000; 355:807-808.
49. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma and metastasis. Radiology 2000; 215:153-161.
50. Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Maekawa K. Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. AJR Am J Roentgenol 2001; 176:661-666.
51. Numata K, Tanaka K, Kiba T, et al. Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma. AJR Am J Roentgenol 176:1199-1205.
52. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response - preliminary results. Radiology 2000; 217:558-563.
53. Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent - early experience. Radiology 1999; 211:643-649.
54. Akhurst T, Larson SM. Positron emission tomography imaging of colorectal cancer. Semin Oncol 1999; 26:577-583.